Skip to main content
. 2016 Apr 11;7(22):32532–32542. doi: 10.18632/oncotarget.8687

Figure 3. Macrophage and leukemic stem cell changes during treatment with RG7356.

Figure 3

A. Macrophage (CD68) frequency and B. leukemic stem cell (CD34) reduction in the bone marrow was shown by immunohistochemistry analysis at baseline (pre-dose cycle 1, day 1 [C1D1]) and on treatment (pre-dose cycle 3, day 1 [C3D1]).